Talk:Locus Biosciences
Add topicAppearance
Latest comment: 3 years ago by Ceyockey in topic CRISPR CAS3 section
| This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||
CRISPR CAS3 section
[edit]I'm thinking that it would be for the best to drop this section. A better treatment would be to present what, if any, enhancements on the technology the company has made. A brief statement related to why the company chose CAS3 vs. CAS9 would be sufficient. This would be a significant change to the article, so I'll not unilaterally make it at this time. --User:Ceyockey (talk to me) 01:31, 20 August 2022 (UTC)
Categories:
- Start-Class pharmacology articles
- Low-importance pharmacology articles
- WikiProject Pharmacology articles
- Start-Class company articles
- Low-importance company articles
- WikiProject Companies articles
- Start-Class virus articles
- Low-importance virus articles
- WikiProject Viruses articles
- Start-Class Molecular Biology articles
- Low-importance Molecular Biology articles
- All WikiProject Molecular Biology pages